Nurcemal Şentürk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nurcemal Şentürk has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Adnan Duha Cömert
Department of Cardiology, Trabzon University, Trabzon, Türkiye
4 shared publications - Fuat Bice
Niksar State Hospital, Tokat, Türkiye
2 shared publications - Abdulrahman Naser
Department of Cardiology, Kırklareli Training and Research Hospital, Kırklareli, Türkiye
1 shared publication - Afag Özyıldız
Recep Tayyip Erdoğan University, Training and Research Hospital, Rize, Türkiye
1 shared publication - Ahmet Karaduman
Department of Cardiology, University of Health Sciences, Hamidiye Faculty of Medicine, Koşuyolu Heart Training and Research Hospital, İstanbul, Türkiye
1 shared publication - Ahmet Tok
Clinic of Cardiology, Bünyan District State Hospital, Kayseri, Türkiye
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 25
Efficacy and safety of combination therapy with statin and ezetimibe in patients failing to achieve target LDL levels at cardiology outpatient clinics in Turkey (COM-TR-OLDL): a real-world observational study
Background: Achieving target low-density lipoprotein cholesterol (LDL-C) levels in patients with atherosclerotic cardiovascular disease (ASCVD) frequently requires combination lipid-lowering therapy. Single-pill combination (SPC) regimens may improve adherence compared with free-dose combinations (FDC) in real-world clinical practice. Methods: This retrospective observational study included 450 ASCVD patients with baseline LDL-C levels of 70–189 mg/dL who were followed in cardiology outpatient clinics between January 2023 and December 2024. Patients received atorvastatin–ezetimibe either as a single-pill combination (SPC, n = 392) or as a free-dose combination (FDC, n = 58). Primary endpoints were LDL-C reduction and treatment adherence (≥ 80% of prescribed doses). Secondary endpoints included LDL-C target attainment and adverse events. Non-parametric tests and chi-square/Fisher’s exact tests were used for statistical analysis. Results: At 1 month, LDL-C levels were significantly lower in the SPC group compared with the FDC group (90.6 vs. 119 mg/dL; p = 0.005), and adherence was higher (89.8% vs. 70.7%; p < 0.001). At 4 months, LDL-C levels were comparable between groups, while continuous adherence remained significantly higher in the SPC group (86% vs. 69%; p = 0.001). A higher proportion of SPC-treated patients achieved LDL-C < 100 mg/dL at 1 month (81.9% vs. 67.2%; p = 0.009). Conclusions: In this real-world ASCVD cohort, SPC therapy with atorvastatin and ezetimibe was associated with superior adherence and comparable lipid-lowering efficacy despite lower statin doses. Fixed-dose combination strategies may represent an effective approach to optimize adherence and cardiovascular risk management.
- 6 May 2026
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 25
Open AccessEfficacy and safety of combination therapy with statin and ezetimibe in patients failing to achieve target LDL levels at cardiology outpatient clinics in Turkey (COM-TR-OLDL): a real-world observational study
Background: Achieving target low-density lipoprotein cholesterol (LDL-C) levels in patients with atherosclerotic cardiovascular disease (ASCVD) frequently requires combination lipid-lowering therapy. Single-pill combination (SPC) regimens may improve adherence compared with free-dose combinations (FDC) in real-world clinical practice. Methods: This retrospective observational study included 450 ASCVD patients with baseline LDL-C levels of 70–189 mg/dL who were followed in cardiology outpatient clinics between January 2023 and December 2024. Patients received atorvastatin–ezetimibe either as a single-pill combination (SPC, n = 392) or as a free-dose combination (FDC, n = 58). Primary endpoints were LDL-C reduction and treatment adherence (≥ 80% of prescribed doses). Secondary endpoints included LDL-C target attainment and adverse events. Non-parametric tests and chi-square/Fisher’s exact tests were used for statistical analysis. Results: At 1 month, LDL-C levels were significantly lower in the SPC group compared with the FDC group (90.6 vs. 119 mg/dL; p = 0.005), and adherence was higher (89.8% vs. 70.7%; p < 0.001). At 4 months, LDL-C levels were comparable between groups, while continuous adherence remained significantly higher in the SPC group (86% vs. 69%; p = 0.001). A higher proportion of SPC-treated patients achieved LDL-C < 100 mg/dL at 1 month (81.9% vs. 67.2%; p = 0.009). Conclusions: In this real-world ASCVD cohort, SPC therapy with atorvastatin and ezetimibe was associated with superior adherence and comparable lipid-lowering efficacy despite lower statin doses. Fixed-dose combination strategies may represent an effective approach to optimize adherence and cardiovascular risk management.
- Open Access
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (6) , 405-406
Evaluation of Reporting Deficiencies, Methodological Gaps, and Hemodynamic Paradoxes in the ScienCrown Transcatheter Valve: A Comprehensive Critical Analysis
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (6) , 405-406
Open AccessEvaluation of Reporting Deficiencies, Methodological Gaps, and Hemodynamic Paradoxes in the ScienCrown Transcatheter Valve: A Comprehensive Critical Analysis
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- Open Access
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (7) , 475-476
Concerns Regarding the Interpretation of Triglyceride-Glucose Index as a Protective Factor in Hypertrophic Cardiomyopathy
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (7) , 475-476
Open AccessConcerns Regarding the Interpretation of Triglyceride-Glucose Index as a Protective Factor in Hypertrophic Cardiomyopathy
- Open Access
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (6) , 401-402
Comment on “Dysregulation of Serum miR-212- 3p Serves as a Biomarker to Predict Disease Onset and Short Term Prognosis in Acute Coronary Syndrome Patients”
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (6) , 401-402
Open AccessComment on “Dysregulation of Serum miR-212- 3p Serves as a Biomarker to Predict Disease Onset and Short Term Prognosis in Acute Coronary Syndrome Patients”
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- Open Access
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (5) , 338-339
Comment on “Delayed-Onset Type 1 Kounis Syndrome Caused Ventricular Fibrillation: A Case Report”
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (5) , 338-339
Open AccessComment on “Delayed-Onset Type 1 Kounis Syndrome Caused Ventricular Fibrillation: A Case Report”
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- 26 September 2024
- Published by Academician Publishing
- p. 81-86
Aortik Psödoanevrizma
- Open Access
- 26 September 2024
- Published by Academician Publishing
Aorta ve Hastalıkları
Aorta Embriyolojisi ve Anatomisi Pelin ALADAĞ Aorta Hastalıklarında Patogenez ve Genetik Özlem SEÇEN Aorta Görüntülenmesinde Ekokardiyografi Kaya ÖZEN Aorta Görüntülemesinde Ultrasonografi Yiğit Can KARTAL Aorta Görüntülemesinde Bilgisayarlı Tomografi ve Manyetik Rezonans Görüntüleme Yiğit Can KARTAL Aortografi ve İntravasküler Ultrason Samet SEVİNÇ Aort Diseksiyonu Esra KOÇ AY İntramural Hematom Seda Elçim YILDIRIM Penetre Aortik Ülser Hamdi TOKÖZ Aortik Psödoanevrizma Nurcemal ŞENTÜRK Travmatik Aort Hasarı İlkin GULİYEV İyatrojenik Aort Diseksiyonu Engin ALGÜL Penetran Aortik Ülser ve İntramural Hematomda Cerrahi Tedavi Oğuz ARSLANTÜRK Aort Diseksiyonunun Cerrahi Tedavisi Barış UYMAZ Torasik Aort Anevrizmasında Tanı ve Tedavi Süleyman AKKAYA Abdominal Aort Anevrizmaları Ardi RREKA Aterosklerotik Aort Hastalıkları Ahmet TOK Leriche Sendromu Tayfur ERDOĞDU EVAR & TEVAR Prosedürü ve Komplikasyonları Hüseyin DURAK Torakal Aort Anevrizmalarının Cerrahi Tedavisi Anıl TEKİN Abdominal Aort Anevrizmalarının Cerrahi Tedavisi Onur GELDİ Dev Hücreli Arterit Zeynep KAYA Cogan Sendromu Abdulrahman NASER Takayasu Arteriti Mehrek BAHRAMISHAD IgG4 İlişkili Hastalık Kenan TOPRAK Sifilitik Aortit Ahmet KARADUMAN Genetik Sendromlarda Aort Tutulumu Güngör ÜSTÜN Biküspid Aortik Kapak Fuat BİCE Aort Koarktasyonu Kenan ERDEM Porselen Aort ve Aort Kalsifikasyonu Devrim KURT Coral Reef Aorta Bilal ÇAKIR Aortik Trombüs Fahri ÇAKAN Fibromusküler Displazi Didar Elif AKGÜN Yavuz Selim AKGÜN Radyasyon ile İlişkili Aortik Hastalıklar Remziye DOĞAN Gebelikte Aort Hastalıkları Zeynep Şeyma TURİNAY ERTOP Aortik Hastalıklarda Anestezik Yaklaşım ve Preoperatif Değerlendirme Yasemin ÇAKIR
- 26 September 2024
- Published by Academician Publishing
Open AccessAorta ve Hastalıkları
Aorta Embriyolojisi ve Anatomisi Pelin ALADAĞ Aorta Hastalıklarında Patogenez ve Genetik Özlem SEÇEN Aorta Görüntülenmesinde Ekokardiyografi Kaya ÖZEN Aorta Görüntülemesinde Ultrasonografi Yiğit Can KARTAL Aorta Görüntülemesinde Bilgisayarlı Tomografi ve Manyetik Rezonans Görüntüleme Yiğit Can KARTAL Aortografi ve İntravasküler Ultrason Samet SEVİNÇ Aort Diseksiyonu Esra KOÇ AY İntramural Hematom Seda Elçim YILDIRIM Penetre Aortik Ülser Hamdi TOKÖZ Aortik Psödoanevrizma Nurcemal ŞENTÜRK Travmatik Aort Hasarı İlkin GULİYEV İyatrojenik Aort Diseksiyonu Engin ALGÜL Penetran Aortik Ülser ve İntramural Hematomda Cerrahi Tedavi Oğuz ARSLANTÜRK Aort Diseksiyonunun Cerrahi Tedavisi Barış UYMAZ Torasik Aort Anevrizmasında Tanı ve Tedavi Süleyman AKKAYA Abdominal Aort Anevrizmaları Ardi RREKA Aterosklerotik Aort Hastalıkları Ahmet TOK Leriche Sendromu Tayfur ERDOĞDU EVAR & TEVAR Prosedürü ve Komplikasyonları Hüseyin DURAK Torakal Aort Anevrizmalarının Cerrahi Tedavisi Anıl TEKİN Abdominal Aort Anevrizmalarının Cerrahi Tedavisi Onur GELDİ Dev Hücreli Arterit Zeynep KAYA Cogan Sendromu Abdulrahman NASER Takayasu Arteriti Mehrek BAHRAMISHAD IgG4 İlişkili Hastalık Kenan TOPRAK Sifilitik Aortit Ahmet KARADUMAN Genetik Sendromlarda Aort Tutulumu Güngör ÜSTÜN Biküspid Aortik Kapak Fuat BİCE Aort Koarktasyonu Kenan ERDEM Porselen Aort ve Aort Kalsifikasyonu Devrim KURT Coral Reef Aorta Bilal ÇAKIR Aortik Trombüs Fahri ÇAKAN Fibromusküler Displazi Didar Elif AKGÜN Yavuz Selim AKGÜN Radyasyon ile İlişkili Aortik Hastalıklar Remziye DOĞAN Gebelikte Aort Hastalıkları Zeynep Şeyma TURİNAY ERTOP Aortik Hastalıklarda Anestezik Yaklaşım ve Preoperatif Değerlendirme Yasemin ÇAKIR